Scheduled within the (Vietnam) GMT +7 timezone and across a week to ensure that you can attend as many sessions as you want.
The first industry session during the featured program starts on Saturday 24th October at your local time below:
- Japan (JST) 13:30
- China (CST) 12:30
- India (IST) 10:00
- Bangladesh (BST) 10:30
- Singapore (SGT) 12:30
- Malaysia (MYT) 12:30
- Australia (AEDT) 15:30
The below clock also shows you the current time compared to the advertised APLAR program (GMT+7)
| 1400-1700 | Pre-Congress workshop CH1 Biomechanics & Movement Workshop with BJC Health Speakers: Errol Lim Managing Director of BJC Health Dr Irwin Lim Consultant Rheumatologist Sarah Comensoli Exercise Physiologist & Manager of Allied Health services Dr Herman Lau Rheumatologist Robyn Yin Head Exercise Physiologist Belinda Price Physiotherapist Blanche Leung Physiotherapist Heidi Kim Physiotherapist Brought to you by  |
|||
| 1130 – 1245 | CH2: Morning symposium 1 “Beyond remission” based on patients’ subjective experiences for improved RA control Chairpersons: Professor Masayoshi Harigai Professor and Chairperson of Department of rheumatology/Tokyo Women’s Medical University Speakers: Associate Professor Yuko Kaneko Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine | CH3: Morning symposium 2 Solving the patient puzzle: A pragmatic approach to SpA management Speakers: Dr Mitsumasa Kishimoto Associate Professor, Department of Nephrology and Rheumatology/Kyorin University School of Medicine Dr Philip Robinson Associate Professor/Brisbane Rheumatology | CH4: Morning symposium 3 New Treatment Paradigm in RA: Focusing on A Novel JAK inhibitor Chairpersons/Speakers: Professor Tatsuya Atsumi Professor of Medicine in the Faculty of Medicine/Hokkaido University Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine | Morning symposium 4 |
Brought to you by  | Brought to you by  | Brought to you by  | ||
| 1315 – 1445 | CH1: Lunch symposium 1 Prospects for JAK inhibitors in the treatment of rheumatoid arthritis Speakers: Dr Kei Ikeda Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital Dr Akio Morinobu Department of Rheumatology, Kyoto University Graduate School of Medicine Brought to you by  | CH2: Lunch symposium 2 Basic and Clinical of Rheumatology Chairpersons: Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School Speakers: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health Brought to you by  |
||
| 1740 – 1840 | CH1: Evening symposium 1 Management of RA in 2020: is remission achievable and where do JAKs fit? Speakers: Professor Gerd-Rüdiger Burmester Medicine Director of the department of Rheumatology Associate Professor Peter Nash Department of Medicine/University of Queensland, Brisbane, AUSTRALIA | CH2: Evening symposium 2 Treat-to-target in SLE: addressing short- and long-term treatment goals Chariperson: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health Speakers: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine/School of Medicine, University of Occupational and Environmental Health Professor Ian Bruce National Institute of Health Research (NIHR) Senior Investigator and Professor of Rheumatology/University of Manchester Professor Nancy Agmon-Levin Consultant/Tel Aviv and Chaim Sheba Medical Center | CH3: Evening symposium 3 ILD in Focus: Time to prioritize the lung in CTDs Chairperson: Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School Speakers: Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence/Nippon Medical School Professor Yannick Allanore Professor of Rheumatology/University of Paris Professor Marco Matucci-Cerinic Professor of Rheumatology and Medicine at the Department of Experimental and Clinical Medicine/Careggi University Hospital of Florence | CH4: Evening symposium 4 Perspectives around the accumulated evidence for IL-6 in autoimmune disease Chairpersons/Speakers: Dr Kunihiro Yamaoka Division of Rheumatology, Kitasato University Hospital, Japan Dr Shinsuke Yasuda Tokyo Medical and Dental University, Department of Rheumatology, Japan |
| Brought to you by | Brought to you by | Brought to you by | Brought to you by  |
|
| 1130 – 1245 | CH2: Morning symposium 5 Treatment of Rheumatoid Arthritis: Past and Future Speakers: Masaru Kato Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University | CH3: Morning symposium 6 To continue, taper or discontinue biologics – Implications on RA treatment outcomes Chairpersons: Professor Yoshiya Tanaka University of Occupational and Environmental Health, Kitakyushu, JAPAN Speakers: Associate Professor Peter Nash Department of Medicine / University of Queensland, Brisbane, AUSTRALIA Associate Professor Khoa Dinh Nguyen Cho Ray Hospital, Ho Chi Minh City, VIETNAM Professor Wen-Chan Tsai Kaohsiung Medical University Hospital, Kaohsiung, TAIWAN | CH4: Morning symposium 7 Denosumab, anti-RANKL antibody, for the treatment of joint destruction in RA. − From DRIVE & DESIRABLE studies Chairpersons: Professor Tatsuya Atsumi Professor of Medicine in the Faculty of Medicine / Hokkaido University Speakers: Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine | |
Brought to you by  | Brought to you by | Brought to you by | ||
| 1315 – 1445 | CH1: Lunch symposium 3 New insights for clinical practice in Spondyloarthritis, SpA Chairpersons: Associate Professor Yuko Kaneko Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine Professor Naoto Tamura Professor and Chairman, Department of Internal Medicine and Rheumatology/Juntendo University School of Medicine Speakers: Dr Kei Ikeda Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital Dr Kenta Misaki Chief Director, Department of Rheumatology/Kita-Harima Medical Center Professor Yuho Kadono Chief Administrator, Orthopedic Surgery/Saitama Medical University | CH2: Lunch symposium 4 Innovative therapeutic alternatives for RA, PsA, AS and nr-axSpA: Individualising the treatment approach Chairperson: Dr Kunihiro Yamaoka Division of Rheumatology, Kitasato University Hospital, Japan Speakers: Dr Kunihiro Yamaoka Division of Rheumatology, Kitasato University Hospital, Japan Professor Lars Erik Kristensen Parker Institute / University Copenhagen Professor Andrew Ostör Cabrini Medical Centre / Emeritus Research |
||
Brought to you by  | Brought to you by |
|||
| 1740 – 1840 | CH1: Evening symposium 5 Addressing Unmet Needs in RA and PsA: The Right Drug for the Right Patient Chairpersons: Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine Speakers: Professor Yoshiya Tanaka Professor and Chairman of the First Department of Internal Medicine / School of Medicine, University of Occupational and Environmental Health Professor Filip Van den Bosch Professor of Rheumatology and Head-of-Clinic, Department of Rheumatology / University Hospital of Ghent University Professor Tsutomu Takeuchi Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine | CH2: Evening symposium 6 Evolution of interleukin-6 inhibiting therapies for rheumatoid arthritis Chairpersons: Dr Yutaka Kawahito M.D., Ph.D. Head of the Department of Inflammation and Immunology/Kyoto Prefectural University of Medicine Speakers: Dr Motomu Hashimoto Department of Advanced Medicine for Rheumatic Diseases, Kyoto University. |
||
Brought to you by  | Brought to you by  |
|||
| 1630-1730 | Evening symposium 3 ILD in Focus: Time to prioritize the lung in CTDs Chairperson: Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence / Nippon Medical School Speakers: Professor Marco Matucci-Cerinic Professor of Rheumatology and Medicine at the Department of Experimental and Clinical Medicine/Careggi University Hospital of Florence Professor Yannick Allanore Professor of Rheumatology / University of Paris Professor Masataka Kuwana Professor of Allergy and Rheumatology and a director of Scleroderma & myositis center of excellence / Nippon Medical School Brought to you by |
|||